acut
viral
bronchiol
clinic
diagnos
condit
caus
signific
morbid
mortal
infanc
children
typic
prodrom
coryz
symptom
includ
rhinorrhea
fever
develop
increas
work
breath
wheez
cough
may
difficulti
feed
young
infant
may
present
apnoea
common
lower
respiratori
tract
condit
common
caus
admiss
hospit
first
month
life
hospitalis
bronchiol
peak
month
life
children
self
limit
ill
manag
commun
although
around
infant
requir
admiss
hospit
last
year
increas
number
children
admit
hospit
bronchiol
unexplain
caus
like
multifactori
although
possibl
use
puls
oximetri
relat
increas
admiss
rate
bronchiol
gener
season
associ
respiratori
viral
infect
commonli
respiratori
syncyti
viru
rsv
death
bronchiol
thought
rare
although
risk
death
increas
substanti
preexist
medic
condit
approxim
death
per
popul
per
year
infant
infect
rsv
respiratori
caus
death
month
uk
acut
viral
bronchiol
remain
caus
substanti
morbid
health
care
cost
young
infant
common
lower
respiratori
tract
condit
common
reason
admiss
hospit
infant
mani
respiratori
virus
associ
acut
viral
bronchiol
although
respiratori
syncyti
viru
rsv
remain
frequent
identifi
viru
infant
mild
self
limit
ill
other
sever
ill
requir
hospit
admiss
need
ventilatori
support
differ
innat
immun
function
respons
respiratori
viral
insult
well
differ
geometri
airway
may
explain
variabl
clinic
pattern
young
age
histori
prematur
remain
import
risk
factor
although
male
gender
indigen
statu
exposur
tobacco
smoke
poor
socioeconom
factor
associ
comorbid
chronic
lung
diseas
congenit
heart
diseas
increas
risk
sever
ill
support
therapi
remain
major
treatment
option
specif
treatment
date
shown
provid
clinic
import
benefit
except
inhal
hyperton
salin
prophylaxi
high
risk
infant
palivizumab
consid
although
cost
effect
still
unclear
mani
question
remain
regard
optim
manag
approach
infant
requir
hospitalis
bronchiol
includ
use
nasogastr
feed
optim
role
supplement
oxygen
optim
use
hyperton
salin
role
combin
therapi
use
heliox
modern
physiotherapi
approach
elsevi
ltd
right
reserv
bronchiol
recurr
episod
wheez
mani
infant
prolong
relaps
symptom
wheez
cough
last
week
month
follow
acut
episod
diagnosi
bronchiol
clinic
base
typic
histori
nasal
discharg
fever
wheezi
cough
examin
find
inspiratori
crackl
andor
expiratori
wheez
gener
agreement
pattern
present
differ
intern
regard
import
crackl
wheez
make
diagnosi
age
rang
recognis
diagnosi
north
america
wheez
regard
import
examin
find
first
month
life
usual
use
defin
bronchiol
earli
present
asthma
wheez
viral
infect
thu
like
overlap
diagnosi
bronchiol
unit
kingdom
presenc
inspiratori
crackl
regard
import
examin
find
first
month
life
usual
use
make
diagnosi
http
wwwsignacuk
differ
diagnost
criteria
use
complic
interpret
clinic
trial
epidemiolog
studi
clinician
assess
patient
make
diagnosi
potenti
overlap
earli
present
asthma
often
lead
trial
asthma
like
therapi
includ
bronchodil
steroid
howev
neither
bronchodil
steroid
shown
provid
clinic
import
benefit
condit
trial
increas
risk
advers
event
cost
condit
may
present
bronchiol
condit
may
similar
present
bronchiol
includ
asthma
pneumonia
airway
lesion
congenit
lung
diseas
diaphragmat
hernia
cystic
fibrosi
congenit
heart
diseas
sepsi
sever
metabol
acidosi
atyp
clinic
find
prolong
symptom
sever
diseas
prompt
investig
airway
epithelium
primari
site
infect
respiratori
virus
bronchiol
viru
may
directli
damag
airway
epithelium
infect
necrosi
cilial
damag
indirectli
promot
inflammatori
respons
result
bronchiolar
obstruct
oedema
accumul
mucu
cellular
debri
airway
increas
sever
may
go
widespread
airway
occlus
major
find
autopsi
specimen
cilial
damag
persist
mani
week
month
follow
acut
bronchiol
grow
interest
role
innat
immun
respons
risk
long
term
wheez
ill
sever
diseas
bronchiol
innat
immun
respons
import
limit
spread
respiratori
viral
infect
within
lung
defect
compon
innat
immun
system
associ
sever
diseas
low
level
interferon
gamma
substanc
p
airway
associ
sever
diseas
one
studi
although
find
led
sever
diseas
unclear
direct
relationship
found
viral
load
theoret
low
substanc
p
level
associ
reduc
secret
mucu
infect
airway
epitheli
cell
particularli
rsv
rhinoviru
rv
lead
activ
nfkb
pathway
induct
varieti
cytokin
chemokin
adhes
molecul
recruit
particularli
neutrophil
also
dendrit
cell
macrophag
lymphocyt
airway
respiratori
virus
stimul
differ
compon
innat
immun
system
like
rsv
evolv
process
impair
apoptosi
infect
airway
epitheli
cell
enhanc
viral
replic
grow
number
virus
associ
bronchiol
although
rsv
remain
commonli
isol
viru
case
case
bronchiol
increas
peak
rsv
season
reinfect
rsv
also
common
even
rsv
season
although
primari
infect
usual
sever
rhinoviru
rv
next
commonli
associ
viru
although
virus
includ
human
metapneumoviru
hmpv
human
bocaviru
enterovirus
adenoviru
influenza
human
coronaviru
parainfluenza
infect
also
associ
bronchiol
one
viru
may
isol
patient
episod
bronchiol
dual
even
tripl
viral
infect
may
detect
rv
rsv
common
dual
infect
conflict
data
regard
associ
type
viru
diseas
sever
studi
suggest
rhinoviru
rsv
may
associ
sever
diseas
effect
dual
infect
also
appear
unclear
conflict
studi
regard
effect
dual
viral
infect
diseas
sever
studi
suggest
concomit
infect
rsv
hmpv
lead
sever
diseas
other
found
increas
sever
dual
infect
virus
concomit
rsv
rv
debat
complic
conflict
studi
examin
associ
increas
sever
rsv
subtyp
effect
viral
load
also
unclear
although
viral
load
reduc
cours
diseas
studi
report
associ
viral
load
increas
clinic
sever
other
found
associ
concurr
sever
bacteri
infect
thought
common
infant
rsv
bronchiol
although
bacteri
infect
lower
respiratori
tract
report
sever
diseas
one
studi
examin
endotrach
aspir
infant
requir
assist
ventil
rsv
posit
bronchiol
three
winter
found
infant
around
bacteria
detect
admiss
paediatr
intens
care
high
bacteri
coloni
count
cfuml
infant
common
bacteri
pathogen
staphylococcu
aureu
haemophilu
influenza
moraxella
catarrhali
streptococcu
pneupmonia
although
unusu
pathogen
also
detect
includ
pseudomona
aeruginosa
ventil
longer
infant
bacteri
coinfect
versu
day
p
unclear
howev
whether
bacteri
lower
respiratori
tract
infect
causal
marker
sever
diseas
atyp
infect
bordatella
pertussi
mycoplasma
pneumonia
simkania
negevensi
chlamydia
like
intracellular
organ
found
water
sampl
also
associ
bronchiol
like
diseas
sever
result
complex
interact
infect
includ
type
characterist
infect
possibl
infect
load
host
factor
includ
airway
size
immun
respons
infant
bronchiol
respiratori
viral
infect
care
requir
avoid
cross
infect
particularli
doctor
wait
room
emerg
depart
hospit
ward
collect
nasopharyng
sampl
rapid
detect
viral
infect
use
enzym
link
immunosorb
assay
polymeras
chain
reaction
elisapcr
test
shown
cost
effect
reduc
hospit
length
stay
combin
appropri
cohort
isol
patient
use
protect
gown
glove
health
care
worker
contact
infect
infant
viral
transmiss
rsv
thought
direct
contact
larg
droplet
fomit
thu
mainstay
infect
control
care
hand
hygien
includ
hand
wash
use
alcohol
rub
contact
patient
along
use
apron
gown
avoid
contamin
cloth
glove
contact
infant
surround
number
virus
detect
nasopharyng
test
vari
depend
local
laboratori
mani
viral
infect
may
miss
virus
look
patient
regard
infecti
two
week
recogn
virus
neg
nasopharyng
test
particularli
import
avoid
transmiss
infect
high
risk
infant
children
hospit
comorbid
increas
risk
sever
diseas
increas
mortal
nosocomi
acquir
respiratori
viral
infect
hospit
visitor
symptom
viral
infect
restrict
health
care
worker
viral
symptom
avoid
contact
high
risk
infant
prematur
infant
infant
congenit
heart
diseas
chronic
lung
diseas
studi
examin
infant
admit
hospit
difficult
separ
risk
factor
bronchiol
risk
factor
sever
diseas
decis
admit
hospit
influenc
mani
differ
medic
social
factor
addit
difficulti
diagnost
criteria
bronchiol
studi
examin
admiss
rate
rsv
infect
oppos
diagnosi
bronchiol
popul
base
studi
although
one
recent
larg
retrospect
popul
studi
us
examin
epidemiolog
featur
incid
bronchiol
among
singleton
birth
mani
risk
factor
modifi
includ
age
gender
underli
medic
condit
infant
older
sibl
increas
risk
acquir
viral
infect
like
admit
hospit
bronchiol
male
increas
risk
bronchiol
also
sever
diseas
hospit
admiss
may
relat
airway
mechan
rel
smaller
airway
compar
femal
increas
risk
wheez
ill
follow
rsv
bronchiol
although
convinc
evid
associ
person
famili
histori
atopi
bronchiol
epidemiolog
studi
new
zealand
australia
also
usa
shown
associ
ethnic
background
risk
bronchiol
sever
diseas
admiss
hospit
indigen
infant
aborigin
maori
first
nation
background
younger
infant
like
admit
hospit
older
infant
bronchiol
thu
time
birth
relat
rsv
season
affect
risk
requir
admiss
hospit
rsv
infant
born
prematur
week
gestat
increas
risk
sever
diseas
hospit
admiss
bronchiol
risk
hospit
admiss
rsv
infect
associ
gestat
age
studi
finland
report
higher
rel
risk
rr
hospit
admiss
infant
born
week
gestat
rr
confid
interv
ci
although
rel
risk
still
increas
infant
born
week
gestat
rr
ci
preexist
diseas
increas
risk
death
infant
rsv
infect
infant
chronic
neonat
lung
diseas
born
week
gestat
increas
risk
sever
diseas
rsv
infect
admiss
hospit
hospit
admiss
rate
report
one
seri
infant
underli
congenit
anomali
chronic
lung
diseas
cystic
fibrosi
even
born
term
also
increas
risk
sever
diseas
admiss
hospit
infant
congenit
heart
diseas
higher
risk
sever
diseas
rsv
infect
account
around
admiss
cohort
studi
also
risk
factor
may
modifi
includ
exposur
environment
tobacco
smoke
socioeconom
factor
protect
factor
breast
feed
parent
smoke
recogn
risk
factor
hospit
admiss
bronchiol
evid
suggest
utero
exposur
tobacco
matern
smoke
postnat
exposur
associ
increas
risk
hospit
admiss
bronchiol
poor
socioeconom
factor
overcrowd
bedroom
share
may
associ
increas
risk
transmiss
respiratori
viral
infect
associ
increas
risk
admiss
rsv
infect
one
small
case
control
studi
risk
hospit
admiss
bronchiol
increas
socioeconom
depriv
score
larg
epidemiolog
studi
infant
mother
year
age
increas
risk
admiss
bronchiol
protect
effect
breast
feed
risk
hospit
rsv
infect
young
infant
report
initi
breast
feed
prior
discharg
hospit
deliveri
associ
increas
risk
admiss
hospit
bronchiol
canada
clinic
trial
use
varieti
clinic
score
system
assess
sever
although
none
shown
use
clinic
set
gener
degre
diseas
sever
assess
histori
clinic
examin
investig
infant
mild
diseas
safe
manag
home
famili
given
adequ
advic
inform
recognis
deterior
child
clinic
statu
diseas
sever
tend
worsen
first
hour
ill
phase
ill
consid
decis
time
review
admiss
hospit
lower
threshold
admiss
hospit
infant
specif
risk
factor
poor
socio
econom
circumst
histori
prematur
congenit
heart
diseas
chronic
lung
diseas
geograph
factor
transport
difficulti
also
need
care
consid
follow
featur
lead
review
referr
hospit
admiss
histori
apnoea
difficulti
feed
may
requir
support
care
infant
taken
less
usual
fluid
intak
preced
hour
hospit
admiss
requir
sever
respiratori
distress
accessori
muscl
use
grunt
respiratori
rate
greater
diagnost
uncertainti
cyanosi
haemoglobin
satur
room
air
around
infant
may
requir
admiss
paediatr
intens
care
criteria
referr
admiss
intens
care
vari
hospit
howev
infant
sever
respiratori
distress
exhaust
failur
maintain
haemoglobin
satur
supplement
oxygen
recurr
apnoea
consid
intens
care
consult
infant
bronchiol
requir
investig
infant
present
admit
hospit
haemoglobin
satur
measur
use
puls
oximetri
help
determin
requir
supplement
oxygen
haemoglobin
satur
room
air
present
emerg
depart
studi
predictor
sever
howev
even
small
differ
valu
may
consider
impact
decis
physician
admit
infant
hospit
infant
bronchiol
seen
emerg
depart
rapid
virolog
test
possibl
rapid
test
may
perform
rsv
point
care
although
shown
reduc
sensit
compar
laboratori
test
may
facilit
appropri
cohort
strategi
rapid
virolog
test
shown
cost
effect
associ
reduc
hospit
stay
reduc
use
antibiot
therapi
reduc
investig
may
reduc
antibiot
prescript
commun
chest
xray
requir
infant
present
mild
diseas
typic
clinic
present
although
infant
sever
ill
infant
atyp
featur
diagnosi
unclear
infant
particular
risk
factor
chest
xray
may
warrant
blood
test
gener
requir
systemat
review
found
advantag
measur
full
blood
count
either
diagnost
decis
therapeut
intervent
although
data
examin
advantag
urea
electrolyt
thought
unlik
derang
unless
sever
diseas
similarli
blood
gase
may
use
assess
infant
potenti
respiratori
failur
otherwis
warrant
routin
bacteriolog
cultur
includ
blood
cultur
urin
cultur
gener
requir
howev
infant
day
age
fever
urin
cultur
febril
infant
acquir
rsv
nosocomi
congenit
cyanot
heart
diseas
requir
intens
care
blood
urin
cultur
perform
infant
requir
assist
ventil
bacteri
cultur
lower
respiratori
tract
secret
manag
acut
viral
bronchiol
good
support
care
infant
requir
specif
measur
manag
home
infant
requir
admiss
hospit
use
clinic
pathway
particularli
specifi
discharg
criteria
reduc
readmiss
rate
reduc
use
inappropri
therapi
infant
haemoglobin
satur
room
air
usual
consid
discharg
emerg
depart
hospit
depend
phase
ill
clinic
social
factor
retrospect
studi
infant
admit
hospit
bronchiol
report
lag
resolut
feed
problem
need
oxygen
supplement
around
day
infant
requir
intens
care
manag
feed
reestablish
oxygen
supplement
appear
major
determin
length
hospit
stay
although
studi
examin
effect
supplement
oxygen
recoveri
bronchiol
data
base
safe
haemoglobin
satur
limit
admiss
discharg
hospit
inde
admiss
nasal
suction
commonli
use
one
us
survey
respons
obtain
physician
contact
physician
recommend
nasal
suction
although
trial
date
assess
benefit
disadvantag
nasal
suction
infant
may
difficulti
feed
increas
respiratori
distress
exhaust
copiou
nasal
secret
frequent
small
feed
may
use
howev
iv
fluid
ng
fluid
may
requir
maintain
adequ
input
hydrat
current
data
base
choic
iv
fluid
ng
feed
issu
warrant
investig
well
design
clinic
trial
bronchodil
commonli
use
manag
bronchiol
usa
although
less
frequent
uk
new
zealand
systemat
review
includ
clinic
trial
children
bronchiol
age
less
month
administ
salbutamol
ipratropium
bromid
adrenerg
agent
report
evid
small
shortterm
improv
clinic
score
doubt
clinic
import
bronchodil
therefor
current
recommend
infant
bronchiol
similarli
systemat
review
use
epinephrin
infant
bronchiol
found
clinic
import
benefit
infant
admit
hospit
although
improv
clinic
score
minut
treatment
seen
children
admit
hospit
clinic
signific
clear
inhal
corticosteroid
use
prevent
post
bronchiol
wheez
systemat
review
studi
involv
infant
found
evid
benefit
although
author
unabl
provid
strong
recommend
felt
number
particip
small
unabl
pool
clinic
outcom
use
system
glucocorticoid
given
oral
intramuscular
intraven
rout
infant
bronchiol
also
examin
systemat
review
thirteen
trial
involv
total
children
manag
either
outpati
hospit
includ
differ
length
stay
clinic
score
readmiss
rate
hospit
admiss
rate
use
system
glucocorticoid
therapi
bronchiol
recommend
recent
larg
random
control
trial
examin
effect
combin
nebulis
epinephrin
oral
dexamethason
administ
emerg
depart
prevent
hospit
admiss
result
suggest
possibl
synergist
effect
combin
drug
although
effect
size
small
infant
would
requir
treatment
prevent
one
admiss
addit
potenti
long
term
consequ
even
short
term
use
high
dose
corticosteroid
young
infant
brain
lung
develop
unclear
treatment
recommend
without
evid
hyperton
salin
improv
mucociliari
clearanc
sever
small
trial
examin
use
hyperton
salin
given
one
studi
without
bronchodil
infant
bronchiol
recent
systemat
review
includ
four
randomis
clinic
trial
conclud
inhal
hyperton
salin
reduc
length
hospit
stay
improv
clinic
sever
score
infant
bronchiol
bacteraemia
uncommon
infant
bronchiol
antibiot
recommend
manag
infant
bronchiol
unless
assist
ventil
requir
andor
bacteri
infect
strongli
suspect
detect
howev
good
qualiti
trial
base
recommend
small
random
control
trial
clarithromycin
infant
suggest
possibl
benefit
reduc
hospit
length
stay
possibl
reduct
readmiss
hospit
larger
random
placebo
control
trial
azithromycin
infant
hospit
rsv
bronchiol
show
benefit
length
stay
resolut
clinic
symtom
inappropri
antibiot
use
expos
children
unnecessari
risk
drug
relat
advers
event
increas
risk
develop
antimicrobi
resist
avoid
cysteinyl
leukotrien
elev
respiratori
secret
infant
rsv
posit
bronchiol
thought
play
role
airway
inflammatori
respons
bronchiol
one
random
control
studi
report
benefit
length
stay
hospit
clinic
sever
score
cytokin
level
nasal
lavag
young
infant
bronchiol
administ
montelukast
leukotrien
receptor
antagonist
larg
random
control
trial
montelukast
administ
infant
age
month
week
follow
either
first
second
episod
rsv
posit
bronchiol
improv
post
bronchiol
respiratori
symptom
ribavirin
recommend
infant
bronchiol
although
may
place
children
post
transplant
studi
poor
qualiti
small
drug
potenti
toxic
difficult
use
chest
physiotherapi
use
respiratori
condit
excess
respiratori
secret
improv
airway
clearanc
systemat
review
includ
three
trial
variabl
qualiti
infant
hospit
acut
bronchiol
requir
paediatr
intens
care
conclud
chest
physiotherapi
use
vibrat
chest
percuss
improv
clinic
sever
score
reduc
length
stay
requir
oxygen
supplement
intens
care
manag
noninvas
ventil
heliox
studi
examin
ventil
strategi
infant
sever
bronchiol
requir
assist
ventil
retrospect
studi
suggest
use
noninvas
ventil
infant
bronchiol
decreas
ventil
associ
pneumonia
reduc
time
requir
supplement
oxygen
administr
heliox
may
improv
densiti
depend
airway
obstruct
grow
interest
examin
effect
differ
respiratori
ill
includ
bronchiol
small
prospect
studi
report
improv
clinic
score
co
level
infant
sever
bronchiol
enhanc
improv
infant
manag
use
noninvas
ventil
heliox
well
design
clinic
trial
requir
examin
intervent
palivizumab
human
murin
monoclon
igg
antibodi
f
protein
rsv
clinic
trial
demonstr
reduc
risk
hospit
rsv
infant
born
prematur
children
age
less
year
haemodynam
signific
congenit
heart
diseas
howev
cost
effect
prophylaxi
less
clear
drug
expens
studi
demonstr
reduc
mortal
addit
drug
appear
less
effect
children
greatest
risk
morbid
mortal
includ
prematur
infant
chronic
lung
diseas
durat
symptom
variabl
use
health
care
resourc
may
reduc
appropri
educ
famili
median
durat
symptom
report
one
studi
day
ci
day
prolong
symptom
experienc
back
baselin
two
week
back
baselin
three
week
four
week
may
help
inform
famili
around
half
infant
otherwis
well
back
baselin
two
week
howev
small
proport
infant
still
symptom
one
month
acut
bronchiol
recogn
increas
risk
recurr
childhood
wheez
ill
follow
earli
rsv
infect
although
risk
develop
atop
diseas
establish
follow
bronchiol
conclus
acut
viral
bronchiol
remain
common
problem
young
infant
particularli
comorbid
effect
therapeut
option
support
care
remain
cornerston
manag
use
hyperton
salin
seem
benefici
use
heliox
non
invas
ventil
infant
sever
diseas
appear
promis
children
bronchiol
self
limit
ill
manag
commun
although
around
infant
requir
admiss
hospit
bronchiol
gener
season
associ
respiratori
viral
infect
commonli
respiratori
syncyti
viru
case
preexist
diseas
increas
risk
sever
ill
death
infant
rsv
infect
particularli
import
avoid
transmiss
infect
high
risk
infant
children
hospit
comorbid
increas
risk
sever
diseas
increas
mortal
nosocomi
acquir
respiratori
viral
infect
support
care
remain
cornerston
manag
bronchiol
although
mani
question
remain
regard
optim
support
care
includ
use
nasal
suction
optim
fluid
manag
nasogastr
intraven
fluid
use
inhal
hyperton
salin
seem
benefici
reduc
clinic
sever
hospit
stay
